Published in Pharma Law Weekly, January 4th, 2005
The ELISPOT platform has led to CTL's position in immune diagnostics. The method is used to determine the effectiveness of vaccines and drugs to stimulate or inhibit the human immune system. The most effective vaccines and immune-stimulating drugs are likely to be those that stimulate a high number of specific white cells to produce key immune stimulation byproducts, known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.